drug: morphine
- Clinical class: narcotic analgesic
- Chemical class: opioid, phenanthrene derivative opium alkaloid
- CSA schedule: II
- DEA number: 9300
- Route of administration: epidural, oral, injected, suppository
- Associated with (substance-related): disorders
- Availability: prescription, street
-
Also: Brompton's mixture
- MEDLINEplus® Drug Information: injection
- MEDLINEplus® Drug Information: oral & rectal
U.S. Preparations:
- Anamorph
- Astramorph/PF (Astra) FDA approved indications: analgesia
- AVINZA® (Ligand) FDA approved indications:
once daily administration indicated for the relief of moderate to severe pain
requiring continuous, around-the-clock opioid therapy for an extended period
of time. 3.20.2002
U.S. Prescribing information
- DepoDur™ (SkyePharma) FDA
approved indications: treatment of pain following major surgery 5.18.2004
U.S. Prescribing information - Duramorph (Elkins-Sinn) FDA approved indications: analgesia
- Kadian® FDA approved indications:
7.0.1996 management of moderate to severe pain where treatment with an opioid analgesic is indicated for more than a few days
U.S. Prescribing information- Kapanol
- Morphine Sulphate ER Tablets (Endo Pharmaceuticals Inc.) FDA approved indications: analgesia
U.S. Prescribing information- MS Contin® (Purdue) FDA approved indications: analgesia
- MSIR® (Purdue) FDA approved indications: analgesia
- Ordine (Mundipharma)
- Oramorph® SR (Roxane Laboratories) FDA approved indications: analgesia
- Roxanol™ (Roxane Laboratories) FDA approved indications: analgesia
- Roxanol 100™ (Roxane) FDA approved indications: analgesia
- Roxanol™-T (Roxane Laboratories) FDA approved indications: analgesia